Table 2.
The characteristics of Epilepsy
| Disease duration | |
| Less than 1 year | 6 (4) |
| One to 5 years | 54 (29.8) |
| More than 5 years | 100 (66.2) |
| Seizure type | |
| Generalized | 29 (19.2) |
| Focal with loss of consciousness | 54 (35.8) |
| Focal without loss of consciousness | 23 (15.2) |
| Absence | 14 (9.3) |
| Myoclonus | 10 (6.6) |
| Unknown onset | 21 (13.9) |
| Antiseizure medications | |
| Monotherapy | 79 (52.3) |
| Polytherapy | 72 (47.7) |
| Other treatment modalities | |
| VNS | 5 (3.3) |
| Surgery | 8 (5.3) |
| Time of the last seizure before the pandemic | |
| Less than 3 months | 58 (38.4) |
| More than 3 months | 93 (61.6) |
| Worsening of seizures during the pandemic | |
| Yes | 35 (23.2) |
| No | 116 (76.8) |
| Last medical review before the pandemic | |
| Less than 3 months | 49 (32.5) |
| Three months or earlier | 102 (67.5) |